Clinical Trial Update: One-Year Study of S1B-509 vs Placebo for Weight Loss [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing S1B-509 to placebo for weight loss in obesity; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• S1B-509

Snippet

Sponsor: S1 Biopharma, Inc. | Conditions: Obesity | Phase 2 | Status: NOT_YET_RECRUITING